Ordinary Adjustment | Solactive Transatlantic Healthcare Equity Index | Effective Date 8th January 2025
Solactive Transatlantic Healthcare Equity Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th January 2025:
FRESENIUS SE & CO KGAA |
GENMAB A/S |
MERCK KGAA |
FRESENIUS MEDICAL CARE AG & CO KGAA |
UCB SA |
SANOFI SA |
NOVARTIS AG |
ROCHE HOLDING AG |
SONOVA HOLDING AG |
ESSILORLUXOTTICA |
LONZA GROUP AG |
AGILENT TECHNOLOGIES INC |
ABBOTT LABORATORIES |
ADDUS HOMECARE CORP |
AMEDISYS INC |
AMGEN INC |
RECORDATI SPA |
COLOPLAST AS CLASS B |
SIEMENS HEALTHINEERS AG |
BECTON DICKINSON AND CO |
BIOGEN INC |
ALCON INC |
SANDOZ GROUP AG |
GSK PLC |
GALDERMA GROUP AG |
BOSTON SCIENTIFIC CORP |
COOPER COMPANIES INC |
QUEST DIAGNOSTICS INC |
DANAHER CORP |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
GE HEALTHCARE TECHNOLOGIES INC |
GILEAD SCIENCES INC |
GLOBUS MEDICAL INC |
HOLOGIC INC |
JOHNSON & JOHNSON |
LABCORP HOLDINGS INC |
MEDTRONIC PLC |
MERIT MEDICAL SYSTEMS INC |
MERCK & CO. INC. |
PRESTIGE CONSUMER HEALTHCARE INC |
PFIZER INC |
QIAGEN NV |
REGENERON PHARMACEUTICALS |
ROYALTY PHARMA PLC- CL A |
STERIS PLC |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |